Mcl-1 is frequently overexpressed in various cancers including ESCC [29, 30], and it protects tumor cells from apoptosis induced by chemotherapeutic agents, such as cytarabine, daunorubicin, and regorafenib [31, 32]. The gene discussed is MCL1; the disease is cancer.